New CEO Forster eyes capital raise for F-star

Immuno-oncology company F-star Biotechnology Ltd. (Cambridge, U.K.) named Eliot Forster as CEO, replacing John Haurum. Forster was CEO of Oxford-based TCR biologics play Immunocore Ltd. (Abingdon, U.K.), which he left in February.

Since becoming CEO in

Read the full 355 word article

User Sign In